Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A combinatorial approach of a polypharmacological adjuvant 2-deoxy-D-glucose with low dose radiation therapy to quell the cytokine storm in COVID-19 management
Amit Verma, Amitava Adhikary, Gayle E. Woloschak, et al.
International Journal of Radiation Biology (2020) Vol. 96, Iss. 11, pp. 1323-1328
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Changes in Glycolytic Pathway in SARS-COV 2 Infection and Their Importance in Understanding the Severity of COVID-19
Adalberto Santos, Pedro Póvoa, Paulo Paixão, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 57
Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications
Pulok K. Mukherjee, Thomas Efferth, Bhaskar Das, et al.
Phytomedicine (2022) Vol. 98, pp. 153930-153930
Open Access | Times Cited: 50
Modelling the DFT structural and reactivity study of feverfew and evaluation of its potential antiviral activity against COVID-19 using molecular docking and MD simulations
Shradha Lakhera, Kamal Devlal, Arabinda Ghosh, et al.
Chemical Papers (2022) Vol. 76, Iss. 5, pp. 2759-2776
Open Access | Times Cited: 46
Technological Advancements in External Beam Radiation Therapy (EBRT): An Indispensable Tool for Cancer Treatment
Krishna Koka, Amit Verma, Bilikere S. Dwarakanath, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 1421-1429
Open Access | Times Cited: 41
Identification of RdRp inhibitors against SARS-CoV-2 through E-pharmacophore-based virtual screening, molecular docking and MD simulations approaches
Hafiz Muzzammel Rehman, Muhammad Sajjad, Muhammad Akhtar Ali, et al.
International Journal of Biological Macromolecules (2023) Vol. 237, pp. 124169-124169
Open Access | Times Cited: 22
2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update
Zoufang Huang, Vivek P. Chavda, Lalitkumar K. Vora, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33
Reprogramming of glucose metabolism in virus infected cells
Priya Goyal, Maitreyi S. Rajala
Molecular and Cellular Biochemistry (2023) Vol. 478, Iss. 11, pp. 2409-2418
Open Access | Times Cited: 16
COVID-19: comprehensive review on mutations and current vaccines
Ananda Vardhan Hebbani, Swetha Pulakuntla, Padmavathi Pannuru, et al.
Archives of Microbiology (2021) Vol. 204, Iss. 1
Open Access | Times Cited: 36
Role of 2-Deoxy-D-Glucose (2-DG) in COVID-19 disease
Kamal K. Sahu, Raman Kumar
Journal of Family Medicine and Primary Care (2021) Vol. 10, Iss. 10, pp. 3548-3552
Open Access | Times Cited: 33
Integrated multi-omics reveals the activated retinal microglia with intracellular metabolic reprogramming contributes to inflammation in STZ-induced early diabetic retinopathy
Kangjia Lv, Ying Hui, Guangyi Hu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis
Jun‐yi Zhu, Guanglei Wang, Xiaohu Huang, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 25
PPAR Ligands Induce Antiviral Effects Targeting Perturbed Lipid Metabolism during SARS-CoV-2, HCV, and HCMV Infection
Marialuigia Fantacuzzi, Rosa Amoroso, Alessandra Ammazzalorso
Biology (2022) Vol. 11, Iss. 1, pp. 114-114
Open Access | Times Cited: 24
Potential Anti-SARS-CoV-2 Prodrugs Activated by Phosphorylation and Their Role in the Aged Population
Vivek P. Chavda, Divya Teli, Pankti C. Balar, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2332-2332
Open Access | Times Cited: 13
2-Deoxy-D-Glucose: A Novel Pharmacological Agent for Killing Hypoxic Tumor Cells, Oxygen Dependence-Lowering in Covid-19, and Other Pharmacological Activities
Raman Singh, Vidushi Gupta, Antresh Kumar, et al.
Advances in Pharmacological and Pharmaceutical Sciences (2023) Vol. 2023, pp. 1-15
Open Access | Times Cited: 11
Repurposing of Chemotherapeutics to Combat COVID-19
Sisir Nandi, Bhabani Shankar Nayak, Mayank Kumar Khede, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 32, pp. 2660-2694
Closed Access | Times Cited: 10
COVID-19
Aloka Samantaray, Edward Johnson, Nishant Kumar, et al.
Indian Journal of Anaesthesia (2021) Vol. 65, Iss. 6, pp. 434-438
Open Access | Times Cited: 12
Computational Analysis Reveals Monomethylated Triazolopyrimidine as a Novel Inhibitor of SARS-CoV-2 RNA-Dependent RNA Polymerase (RdRp)
Anandakrishnan Karthic, Veerbhan Kesarwani, Rahul Singh, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 801-801
Open Access | Times Cited: 8
Computational screening for investigating the synergistic regulatory potential of drugs and phytochemicals in combination with 2-deoxy-D-glucose against SARS-CoV-2
Anshika Gupta, Shweta Singh Chauhan, Anamika Singh Gaur, et al.
Structural Chemistry (2022) Vol. 33, Iss. 6, pp. 2179-2193
Open Access | Times Cited: 5
Proteomics advances towards developing SARS-CoV-2 therapeutics using in silico drug repurposing approaches
Amrita Mukherjee, Ayushi Verma, Surbhi Bihani, et al.
Drug Discovery Today Technologies (2021) Vol. 39, pp. 1-12
Open Access | Times Cited: 7
Low-Dose Radiotherapy for Patients with Pneumonia Due to COVID-19: A Single-Institution Prospective Study
T. Rutkowski, Jerzy Jaroszewicz, Damian Piotrowski, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 858-858
Open Access | Times Cited: 2
Nano-based techniques: A revolutionary approach to prevent covid-19 and enhancing human awareness
Annamalai Asaikkutti, Karuppaiya Vimala, E. Dhineshkumar, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 86, pp. 104567-104567
Open Access | Times Cited: 2
A hitchhiker's guide through the COVID-19 galaxy
Susanna Felsenstein, Andreas Reiff
Clinical Immunology (2021) Vol. 232, pp. 108849-108849
Open Access | Times Cited: 4
The Omic Insights on Unfolding Saga of COVID-19
Arvinpreet Kaur, Mehak Chopra, Mahak Bhushan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 4
Impact of X-radiation in the management of COVID-19 disease
Divya Mohan, K Nandhini, Venkateswarlu Raavi, et al.
World Journal of Radiology (2022) Vol. 14, Iss. 7, pp. 219-228
Open Access | Times Cited: 2
2-Deoxy-D-glucose (2-DG) for treatment of moderate to severely ill COVID-19 patients: A retrospective case series
Praveen Chandra, Bornali Dutta, Sandeep Mittal, et al.
Journal of Medical Case Reports and Case Series (2021)
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top